Skip to content

IPHA

Innate Pharma SA

NASDAQ · Healthcare · Biotechnology · FR

$1.90
−0.52%
Ask drillr

Margins

Gross margin
1701.9%
EBITDA margin
-4848.5%
EBIT margin
-4598.8%
Net margin
-4383.5%
FCF margin
-4142.3%
117.3%
Return on equity
-136.9%
Return on assets
168.1%
Return on invested capital
0.02x
Asset turnover
-$51.3M
Cash from operations
$0.11
Cash per share

Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026